移植与宿主疾病的药物遗传学:通往个性化医学的道路
Piotr Łacina1, Jagoda Siemaszko1, Katarzyna Bogunia-Kubik1
1Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
药物遗传学可以在干细胞移植后个性化移植对宿主疾病 (GvHD) 治疗. 了解基因变异可以优化药物选择和剂量,以更好地管理GvHD并减少副作用.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药物遗传学 药物遗传学
背景情况:
- 移植与宿主疾病 (GvHD) 是全原造血细胞干细胞移植 (HSCT) 的一个主要并发症.
- 目前的GvHD预防和治疗策略需要不断改进,以减少发病率和死亡率.
- 个性化医疗方法在优化患者护理方面越来越重要.
研究的目的:
- 审查药物遗传变异在GvHD的预防和管理中的作用.
- 探索药理遗传学如何个性化GvHD治疗策略.
- 突出将药物遗传学纳入GvHD.临床实践的需要.
主要方法:
- 与GvHD相关的药物遗传研究的文献综述.
- 对影响关键GvHD药物的药物遗传变异分析:氨酸抑制剂,甲铁酸,氨酸莫菲蒂尔,环胺和皮质类固醇.
- 对GvHD预防和治疗中的药物遗传学现有证据的综合.
主要成果:
- 药物遗传变异显著影响GvHD预防和治疗剂的疗效和毒性.
- 特定的遗传特征可以预测患者对某些免疫抑制剂的反应和不良事件的风险.
- 基于药物遗传学的个性化药物选择和剂量有望改善GvHD的结果.
结论:
- 药物遗传学提供了一个强大的工具来定制GvHD预防和治疗,朝着HSCT的精准医学迈进.
- 进一步的药物遗传学关联研究对于扩大证据基础至关重要.
- 药物遗传检测的临床实施对于优化GvHD管理和患者护理至关重要.
更多相关视频
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
08:07Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
